Development of a novel orally active peptide for the treatment of pain [ 2008 - 2010 ]

Research Grant

Researchers: Prof David Craik (Principal investigator) ,  Dr Richard Clark

Brief description Chronic pain from damage to the nervous system is difficult to treat. A new type of drug has recently been developed from sea snail venom to treat chronic pain but is given by injection, which limits its use. Our research has developed a stable molecule that has analgesic activity when ingested. This proposal focuses on further testing to fully establish this molecule's therapeutic potential. This information can then attract a commercial partner to bring the new drug into general use.

Funding Amount $AUD 402,145.85

Funding Scheme NHMRC Development Grants

Notes Development Grant